Medtech Talk
Medtech Talk
Healthegy
ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology
27 minutes Posted Aug 11, 2016 at 4:00 am.
0:00
27:34
Download MP3
Show notes
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.